Apnimed, Inc.
NASDAQ:APMDBiotechnology
+$0.71 today
- Market cap
- $726.46M
- Beta
- 0.00
Volume 0.30M
Average 1.15M
APMD Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Cash & Equivalents history
Currency unavailable · from the balance sheet
No Cash & Equivalents data reported for this period type.
Cash & Equivalents vs competitors
How APMD compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $127.76M USD | +19.5% | -38.1% | 13.8% | |
| Mar 2026 | €12.98M EUR | -42.0% | +18.8% | 13.3% | |
APMDApnimed, Inc. | — | — | — | — | — |
| Peer median (excluding APMD) | — | -11.3% | -9.6% | 13.5% | |
Competitors are the stored peer set for APMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Apnimed, Inc.
NASDAQ:APMD
Intrinsic Alpha fair value
Locked
Current Price
$17.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.